EC Approves Pfizer’s HYMPAVZI™ (marstacimab) for Treatment of Adults and Adolescents with Severe Hemophilia
On Nov, 20, 2024, Pfizer announced that the European Commission (EC) has granted marketing authorization for HYMPAVZIâ„¢ (marstacimab)…
On Nov, 20, 2024, Pfizer announced that the European Commission (EC) has granted marketing authorization for HYMPAVZIâ„¢ (marstacimab)…
On Nov. 20, 2024, a research collaboration between the Texas A&M College of Veterinary Medicine and Biomedical Sciences…
On Nov. 19, 2024, the California Department of Public Health (CDPH) reported it has identified a possible bird…
On Nov. 19, 2024, the World Health Organization (WHO) announced it had granted Emergency Use Listing (EUL) to Japan-based…
On Nov. 16, 2024, the California Department of Public Health (CDPH) announced it had identified through laboratory testing…
On Nov. 16, 2024, the U.S. Centers for Disease Control and Prevention (CDC) and public health officials in…
On Nov. 15, 2024, researchers from Queen Mary University of London and the the University of Hong Kong…
On Nov. 15, 2024, a University of California Davis Health (UC Davis Health) research team announced they had…
On Nov. 15, 2024, a team led by researchers from Sweden’s Karolinska Institutet reported study results that showed…
On Nov. 15, 2024, the U.S. Centers for Disease Control and Prevention (CDC) confirmed a highly pathogenic avian…
On Nov. 15, 2024, The Hawai‘i Department of Agriculture (HDOA) received confirmation from the U.S. Department of Agriculture…
On Nov. 14, 2024, officials at the Woodland Park Zoo in Seattle announced that a red-breasted goose had…
On Nov. 14, 2024, the March of Dimes released its 2024 Report Card, revealing the U.S. preterm birth…
On Nov. 14, 2024, the U.S. Food and Drug Administration approved PTC Therapeutics’ Kebilidi (eladocagene exuparvovec-tneq), an adeno-associated…
On Nov. 14, 2024, an analysis from the Global Burden of Disease Study Collaborator Network warned of an…
On Nov. 13, 2024, the NCD Risk Factor Collaboration (NCD-RisC) with support from the World Health Organization (WHO)…
On Nov. 13, 2024, a study published in JAMA Network Open showed that respiratory syncytial virus (RSV) was…
On Nov. 12, 2024, researchers from the University of Basel and University Hospital Basel announced they had developed…
On Nov. 12, 2024, researchers from the University of California, San Francisco (UCSF) reported that their genomic test…
On Nov. 12, 2024, researchers led by Nico Sommerdijk from Radboud university medical center in Nijmegen (Netherlands) announced…
On Nov. 11, 2024, findings from two studies have tied use of the antiviral drug nirmatrelvir-ritonavir (Paxlovid) to…
On Nov. 11, 2024, a team of researchers led by Iowa State University (ISU) have shown that as…
On Nov. 9, 2024, the World Health Organization announced that three additional countries had confirmed travel-related cases of…
On Nov. 9, 2024, the BC Centre for Disease Control’s Public-Health Laboratory reported that an an individual in…
On Nov. 7, 2024, researchers reported that Implementation of routine immunization of U.S. adolescents with the quadrivalent (four-strain)…
On Nov. 7, 2024, a team of scientists announced that DNA analysis of Pompeii victims who perished during…
On Nov. 6, 2024, a trio of new studies with funding from Cancer Grand Challenges revealed the unfair advantage…
On Nov. 6, 2024, the World Health Organization announced that the Access and Allocation Mechanism (AAM) for mpox…
On Nov. 6, 2024, researchers from the Pasteur Institute in Cambodia published a detailed genetic analysis of the…
On Nov. 6, 2024, data from the VENUS (Vaccine Effectiveness, Networking, and Universal Safety) study in Japan revealed…